【摘 要】
：
Objective:To provide evidence on the efficacy and safety of Chinese herbal medicine (CHM)as interventions for systemic lupus erythematosus (SLE).Methods:Seven electronic databases,including the Cochrane Library,Chinese National Knowledge Infrastructure (C
【机 构】
：
Centre for Evidence-Based Chinese Medicine,Beijing University of Chinese Medicine,Beijing 100029 ,Ch
论文部分内容阅读
Objective:To provide evidence on the efficacy and safety of Chinese herbal medicine (CHM)as interventions for systemic lupus erythematosus (SLE).Methods:Seven electronic databases,including the Cochrane Library,Chinese National Knowledge Infrastructure (CNKI),Chinese Scientific Journal Database(VIP),Chinese Biomedical Literature Service System (SinoMed),Wanfang,Embase,and PubMed,were comprehensively searched,from their inception to August 16,2020,for all randomized controlled trials(RCTs) that focused on CHM used alone or in combination with conventional medicine for SLE.Outcomes were SLE activity index (SLEDAI),traditional Chinese medicine symptom/syndrome score (TCMSS),dosage of glucocorticoids,main serological testing,and incidence of adverse events.Data were extracted and pooled using Review Manager 5.3 software.Results:A total of 13 RCTs enrolling 856 participants met our inclusion criteria.Meta-analyses showed that,compared to placebo,CHM had statistically significant effect on reducing SLEDAI score (MD=-1.74,95％ CI:-2.29 to-1.18),diminishing TCMSS (SMD=-0.89,95％ CI:-1.16 to-0.62),decreasing dosage of glucocorticoids (MD=-2.41 mg/d,95％ CI:-3.34 to-1.48),lowering erythrocyte sedimentation rate(MD=-4.78 mm/h,95％ CI:-8.86 to-0.71),and increasing serum complement C4 level (MD=0.03 mg/dL,95％CI:0.00 to 0.06).No significant difference was found between CHM and placebo on adverse events.Conclusions:CHM provided significant beneficial effect on controlling disease activity and reducing dose of glucocorticoids used among SLE patients.Future advanced designed RCTs for CHM treating moderate to severe SLE with multicenter and longer follow-up are urgently needed.
其他文献
Objective:To evaluate the protective effects of Astragaloside Ⅳ(AST)in a rat model of myocardial injury induced by cecal ligation and puncture(CLP).Methods:The model of sepsis-induced cardiac dysfunction was induced by CLP.Using a random number table,50 s
Objective:To investigate the molecular mechanisms underlying the effects of arsenic trioxide(As2O3) in combination with leflunomide on the hamster-to-rat heart xenotransplant.Methods:Transplantation of LVG hamster hearts to Lewis rats was performed by ana
Objective:To elucidate the active compounds and the molecular mechanism of Cyathula Officinalis as a drug treatment for rheumatoid arthritis (RA).Methods:The target genes of active ingredients from Cyathula Officinalis were obtained from bioinformatics an
Objective:To examine the role of carvacrol in modulating PI3K/AKT signaling involved in human breast cancer pathogenesis using in vitro experimental model MCF-7 cells.Methods:MTT and lactate dehydrogenase assays were performed with cells treated with diff
Bee venom (BV),one of the most commonly encountered types of animal venom,consists of a mixture of chemical agents that cause allergic reactions in the human body.(1) BV therapy,in which BV is exploited for medicinal purposes,is available worldwide,mainly
Objective:To analyze clinical feature and information of medication to explore the risk signals of preparations containing Psoraleae Fructus(BGZP)related with hepatobiliary adverse drug reactions(ADR),in order to reinforce pharmacovigilance.Methods:A retr
Objective:To study the mechanism of the anti-tumor effect of Morinda citrifolia (noni).Methods:The influences of noni juice on cell proliferation,apoptosis,invasion,migration and the activity of AKT/nuclear factor-κ B (NF-κ B) signaling pathway in A549 hu
Objective:To assess the clinical effectiveness of acupoint application(AP)of Guan Xin Su He Pill(冠心苏合丸,GXSHP)for patients with chronic stable angina pectoris(CSAP).Methods:This study was carried out in 3 local hospitals in Chengdu,China.After baseline eva
The history of acupuncture anesthesia dates back to August 30,1958 in Shanghai First People\'s Hospital,Shanghai,China.Dr.YIN Hui-zhu,an otolaryngologist conducted a tonsillectomy under acupuncture of Hegu(LI 4)in each hand without any other anesthetics
Objective:To evaluate the effect of Danhong Injection(丹红注射液,DH)on the index of microcirculatory resistance(IMR)and myocardial injury in patients with unstable angina undergoing elective percutaneous coronary intervention(PCI).Methods:Seventy-eight patient